DCL: Explanation for consolidated business result in QIII/2012

Cuu Long Pharmaceutical Joint Stock Corporation (PHARIMEXCO) explained the fluctuation in consolidated profit in Quarter III/2012 compared to Quarter III/2011 as follows:

-         Consolidated profit after tax in Quarter III/2012: VND7,430,966,651

-         Consolidated profit after tax in Quarter III/2011: VND8,765,186,466

By: million dongs

	Quarter 3/2012	Quarter 3/2011	Different
			Value	%
Net revenue	157,780	178,048	-20,268	-12.84
Cost of goods sold	113,437	129,083	-15,646	-13.80
Gross profit	44,343	48,965	-4,652	-10.42

-         The consolidated profit after tax in Quarter III/2012 decreased by VND1,334,219,815 (equivalent to 10%) compared to the consolidated profit after tax in Quarter III/2011 because the prices of raw materials in Quarter III/2012 was higher than in Quarter III/2011, leading to Cost of goods sold increased and Gross profit decreased.

HOSE

>   TNT: Explanation for consolidated business result in Quarter 3/2012 (14/11/2012)

>   SRC: Announcement of changes in business license (14/11/2012)

>   VNH: Explanation for consolidated business result in Q3.2012 (14/11/2012)

>   HU3: Explanation for consolidated business results in quarter 3/2012 (14/11/2012)

>   SAM: Explanation for consolidated business result in Q3/2012 (14/11/2012)

>   VC3: Financial Statement Quarter 3/2012 (consolidated) (14/11/2012)

>   VC3: Financial Statement Quarter 3/2012 (holding company) (14/11/2012)

>   POT: Financial Statement Quarter 3/2012 (holding company) (14/11/2012)

>   ACB: Explanation for operating result in QIII- 2012 (Consolidated) (13/11/2012)

>   VE8: Financial Statement Quarter 3/2013 (13/11/2012)